Eli Lilly and Company (LLY) Cash Flow Statement
Eli Lilly and Company (LLY) generated $28.1B of operating cash flow over the twelve months to 2026-06-30, spent $9.9B on capital expenditure and had free cash flow of $18.2B, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LLYEli Lilly and CompanyFollow LLY — free
—
Price chart with a free account
- Market cap
- 1.20T
- P/E TTM
- 42.7
- Dividend yield
- 0.5%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.34 | 6.86 | 7.23 | 5.30 | 5.74 | 4.46 | 2.96 | 4.85 | 5.62 | 5.52 | 4.84 | 6.50 | 7.37 | 7.59 | 4.24 | 8.82 | 16.81 | 28.08 | |
| Capital expenditure | 0.77 | 0.69 | 0.67 | 0.91 | 1.01 | 1.16 | 1.07 | 1.04 | 1.08 | 1.21 | 1.03 | 1.39 | 1.31 | 1.85 | 3.45 | 5.06 | 7.84 | -9.89 | |
| Free cash flow | 3.57 | 6.16 | 6.56 | 4.40 | 4.72 | 3.30 | 1.90 | 3.81 | 4.54 | 4.31 | 3.80 | 5.11 | 6.06 | 5.73 | 0.79 | 3.76 | 8.97 | 18.19 | |
| Dividends paid | 2.15 | 2.17 | 2.18 | 2.19 | 2.12 | 2.10 | 2.13 | 2.16 | 2.19 | 2.31 | 2.41 | 2.69 | 3.09 | 3.54 | 4.07 | 4.68 | 5.38 | — | |
| Share repurchases | — | — | — | 0.72 | 1.70 | 0.80 | 0.75 | 0.60 | 0.30 | 4.15 | 4.40 | 0.50 | 1.25 | 1.50 | 0.75 | 2.50 | 4.11 | — | |
| Stock-based compensation | 0.37 | 0.23 | 0.15 | 0.14 | 0.14 | 0.16 | 0.22 | 0.26 | 0.28 | 0.28 | 0.31 | 0.31 | 0.34 | 0.37 | 0.63 | 0.65 | 0.63 | — |
USD billions · SEC XBRL
Eli Lilly and Company — questions
- What is Eli Lilly and Company's operating cash flow?
- $28.1B over the twelve months to 2026-06-30.
- How much does Eli Lilly and Company spend on capital expenditure?
- $9.9B over the twelve months to 2026-06-30.
- What is Eli Lilly and Company's free cash flow?
- $18.2B over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Eli Lilly and Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.